Canadian Journal of Gastroenterology and Hepatology / 2018 / Article / Tab 5

Research Article

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

Table 5

Association of type 2 diabetes mellitus with various predictors.

No T2DM 
(mean±SEM or 
Absolute (relative) 
(mean±SEM or 
Absolute (relative) 
POR (univariate logistic regression)95%CI

Age (years)58±163±1<0.00011.041.02-1.07

Male sex115 (42.6)45 (51.1)0.1621.410.87-2.28

BMI (kg/m2)26.6±0.2728.5±0.60.0011.0991.035-1.167

HCV RNA (IU/mL)2 776 629±347 1762 937 405±434 0130.2591.2250.862-1.741

Treatment experienced187 (69.3)65 (73.9)0.4111.2540.73-2.16

Elastography (kPa)12.5±0.8613.6±

F4 fibrosis (elastography)113 (42.2)54 (61.4)0.0042.671.45-4.91

F3 fibrosis (elastography)60 (22.4)17 (19.3)0.2271.580.75-3.34

Duration of HCV infection10.44±0.4410.56±0.850.9001.0020.97-1.047

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.